Skip to main content
. 2022 Feb 14;10(2):366. doi: 10.3390/healthcare10020366

Table 1.

Gas chromatography–mass spectrometry (GC-MS) analysis.

N. Compound a Rt b RAP c
1 α-Pinene 6.33 2.72 ± 0.09
2 Camphene 6.63 0.12 ± 0.01
3 β-Pinene 7.20 0.85 ± 0.07
4 β-Myrcene 7.47 1.50 ± 0.10
5 3-Carene 7.81 1.85 ± 0.14
6 Isocineole 7.88 0.26 ± 0.01
7 Limonene 8.16 3.91 ± 0.12
8 4-Carene 8.24 Tr d
9 α-Ocimene 8.40 Tr
10 Linalool 9.25 10.70 ± 0.55
11 1-p-menthol 9.83 0.47 ± 0.02
12 Acetophenone 10.27 0.13 ± 0.01
13 α-terpineol 10.43 3.31 ± 0.15
14 Citronellol 10.86 1.73 ± 0.09
15 Anthranilic acid 10.95 6.43 ± 0.60
16 Geraniol 11.09 1.52 ± 0.20
17 1,4-dimethyl-4-vinylciclohexene 11.29 1.30 ± 0.08
18 Fenchyl acetate 11.35 0.49 ± 0.02
19 Indole 11.66 0.21 ± 0.01
20 Geranyl acetate 12.15 3.21 ± 0.23
21 Tridecanol 12.80 2.28 ± 0.18
22 Nerolin 13.44 1.47 ± 0.16
23 Nerolidol 13.63 0.29 ± 0.01
24 Farnesol 14.62 1.20 ± 0.05

Notes: a Major compounds listed in order of elution from SE30 MS column; b Retention time (as min); c Relative area percentage (peak area relative to total peak area in total ion current (TIC) %); d Tr: Traces percentages < 0.1%. Data are expressed as mean ± standard deviation (n = 3) of 3 independent experiments.